Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

Clinical trial NCT00131742 · COMPLETED

Trial details

NCT number: NCT00131742
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2004-07-01
Primary completion: 2007-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.